Arcus Biosciences, Inc.
RCUS·03969F109·US·Common Stock·Healthcare - Biotechnology-Activist
RCUS (Arcus Biosciences, Inc.) is held by 120 institutional investors as of Q2 2026. Largest holders: BlackRock, Inc. ($506.1M), STATE STREET CORP ($185.9M), WELLINGTON MANAGEMENT GROUP LLP ($181.8M). Net institutional sentiment: Mixed.
120
Holders
(8 Elite)
$2.3B
Total Value
58% (125)
Consensus
73 buying - 52 selling
13F: Insider & Congress: Updated regularly
Who's Trading
Source dates: Price Aug 28, 2026 · Insiders Aug 24, 2026 · Activists Aug 7, 2026 · Congress none
InsiderAAAzoy AlexanderExercise 3K shAug 21, 2026
InsiderAAAzoy AlexanderSell $85KAug 21, 2026
ActivistGSGilead Sciences, Inc.24.7%Aug 7, 2026
Checking access…
Top Holders
Checking access…
Showing 1-20 of 132
1 / 7
Continue exploring
Other Healthcare stocks held by institutions
403 holders · $856.6B
403 holders · $286.8B
388 holders · $148B
385 holders · $405.5B
384 holders · $95B
381 holders · $105.8B
378 holders · $226B
375 holders · $51.2B
373 holders · $296.3B
371 holders · $110.7B
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer